Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated-Interferon and Ribavirin in HIV/HCV Co-infected Patients in Asia
NCT01838772Phase 4Completed
- Sponsor
- amfAR
- Start
- Dec 2013
- Primary completion
- Jun 2016
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 4
01
Overview
A Phase 4 trial of peginterferon alfa-2b, ribavirin in hepatitis C (HCV), sponsored by amfAR. Started Dec 2013; status: completed.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01838772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838772.